These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33838398)

  • 1. Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.
    Liberman AR; Bromberg DJ; Azbel L; Rozanova J; Madden L; Meyer JP; Altice FL
    Int J Drug Policy; 2021 Aug; 94():103209. PubMed ID: 33838398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
    Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.
    Meyer JP; Culbert GJ; Azbel L; Bachireddy C; Kurmanalieva A; Rhodes T; Altice FL
    Harm Reduct J; 2020 Oct; 17(1):86. PubMed ID: 33129341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.
    Liberman AR; Bromberg DJ; Litz T; Kurmanalieva A; Galvez S; Rozanova J; Azbel L; Meyer JP; Altice FL
    PLoS One; 2022; 17(10):e0276723. PubMed ID: 36282864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing methadone maintenance therapy into Ukrainian prisons: a qualitative study of criminal subculture, Russia's full-scale invasion, and contested methadone objects.
    Ponticiello M; Azbel L; Tate MM; Bromberg DJ; Pykalo I; Kiriazova T; Saichuk N; Altice FL
    Front Psychiatry; 2023; 14():1227216. PubMed ID: 38098632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
    O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
    J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
    Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of Health-Related Community Reentry Challenges among Incarcerated Drug Users in Azerbaijan, Kyrgyzstan, and Ukraine.
    Rozanova J; Morozova O; Azbel L; Bachireddy C; Izenberg JM; Kiriazova T; Dvoryak S; Altice FL
    J Urban Health; 2018 Aug; 95(4):508-522. PubMed ID: 29728898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan.
    Azbel L; Rozanova J; Michels I; Altice FL; Stöver H
    Harm Reduct J; 2017 Jul; 14(1):43. PubMed ID: 28693573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
    Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons.
    Komalasari R; Wilson S; Haw S
    Int J Drug Policy; 2021 Jan; 87():102978. PubMed ID: 33129135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of HIV risk and outcomes in a nationally representative sample of incarcerated women in Azerbaijan, Kyrgyzstan, and Ukraine.
    Ranjit YS; Azbel L; Krishnan A; Altice FL; Meyer JP
    AIDS Care; 2019 Jul; 31(7):793-797. PubMed ID: 30701981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A social ecological model (SEM) to exploring barriers of and facilitators to the implementation of opioid agonist treatment (OAT) programmes in prisons.
    Komalasari R; Wilson S; Haw S
    Int J Prison Health; 2021 Nov; 17(4):477-496. PubMed ID: 38902897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova.
    Dorgay CE; Bromberg DJ; Doltu S; Litz T; Galvez S; Polonsky M; Dvoryak S; Altice FL
    Int J Drug Policy; 2022 Jun; 104():103683. PubMed ID: 35417790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.
    Nunn A; Zaller N; Dickman S; Trimbur C; Nijhawan A; Rich JD
    Drug Alcohol Depend; 2009 Nov; 105(1-2):83-8. PubMed ID: 19625142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
    Bazazi AR; Culbert GJ; Wegman MP; Heimer R; Kamarulzaman A; Altice FL
    BMC Infect Dis; 2022 Nov; 22(1):837. PubMed ID: 36368939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.